Stout Jay S
Stout Jay S, CTO, reported an open-market or private sale at Immunovant, Inc. involving 2595.000000 shares for an estimated $75099.30. Reported holdings after the transaction were 198937.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 21, 2026
- Filing date
- Oct 23, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 201,532 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IMVT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001764013-26-000114 Common Stock
- Transaction date
- Oct 21, 2026 Filed Oct 23, 2026, 08:55 PM · 2d delay
- Shares
- 2,595 sh $28.94 per share
- Estimated value
- -$75.0k Computed from shares × price
- Holdings after
- 198,937 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Technology Officer
- F1
On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17,
2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is
mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Rep…
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.31 - $29.15 per share, inclusive. The Reporting Person undertakes to provide
to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with…
range set forth in this footnote to this Form 4.
0 other transactions
0 recent txs